APP announced that it will launch Imipenem and Cilastatin for Injection and Meropenem for Injection, generic versions of Primaxin IV (Merck) and Merrem IV (AstraZeneca), respectively. It is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results